Comparing Cefepime Versus Cefazolin Plus Ceftazidime for CAPD-associated Peritonitis
Status:
Completed
Trial end date:
2016-11-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy of empirical antibiotics of
CAPD-associated peritonitis with intraperitoneal, continuous dosing of cefepime monotherapy
versus combination of cefazolin and ceftazidime. Patients were randomized to be administered
either intraperitoneal cefepime 1 g loading then 250 mg all exchanges (treatment group) or
cefazolin and ceftazidime (control group) in the same dose.
Phase:
Phase 4
Details
Lead Sponsor:
Chulalongkorn University
Collaborators:
Siam Pharmaceutical Co Ltd The Kidney Foundation of Thailand